| Nov 18 |
Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
|
| Nov 15 |
Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024
|
| Nov 14 |
Aurinia to Participate in Jefferies London Healthcare Conference
|
| Nov 8 |
Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon
|
| Nov 8 |
Aurinia slashes workforce by 45% to focus on lupus and autoimmune assets
|
| Nov 8 |
Aurinia Pharmaceuticals Inc (AUPH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
|
| Nov 7 |
Aurinia stock jumps 14% on Q3 earnings, restructuring announcement
|
| Nov 7 |
Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
Aurinia Pharmaceuticals (AUPH) Q3 Earnings and Revenues Beat Estimates
|
| Nov 7 |
Aurinia: Q3 Earnings Snapshot
|
